R. Brian Mitchell

1.8k total citations · 1 hit paper
17 papers, 1.4k citations indexed

About

R. Brian Mitchell is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, R. Brian Mitchell has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in R. Brian Mitchell's work include Lung Cancer Treatments and Mutations (5 papers), DNA Repair Mechanisms (4 papers) and Lung Cancer Research Studies (3 papers). R. Brian Mitchell is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), DNA Repair Mechanisms (4 papers) and Lung Cancer Research Studies (3 papers). R. Brian Mitchell collaborates with scholars based in United States, United Kingdom and Mexico. R. Brian Mitchell's co-authors include R C Moschel, J.T. Thigpen, Martee L. Hensley, M. Eileen Dolan, M. Eileen Dolan, A E Pegg, M E Dolan, Todd H. Wasserman, Bahman Emami and William J. Gradishar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

R. Brian Mitchell

17 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants

2008 378 citations Martee L. Hensley, Karen L. Hagerty et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Brian Mitchell United States	11	518	478	363	197	188	17	1.4k
Richard A. Bender United States	22	587 1.1×	857 1.8×	260 0.7×	47 0.2×	514 2.7×	69	1.9k
Arnaldo Arbini United States	25	905 1.7×	433 0.9×	248 0.7×	136 0.7×	396 2.1×	55	1.9k
Po‐Min Chen Taiwan	23	500 1.0×	705 1.5×	243 0.7×	64 0.3×	170 0.9×	87	1.9k
W. Jeffrey Petty United States	28	886 1.7×	1.2k 2.5×	1.0k 2.9×	97 0.5×	188 1.0×	110	2.6k
Myrna Candelaria Mexico	25	1.4k 2.7×	563 1.2×	272 0.7×	34 0.2×	243 1.3×	88	2.5k
Raffaele Longo Italy	19	567 1.1×	571 1.2×	297 0.8×	44 0.2×	326 1.7×	64	1.5k
Farkas Vánky Sweden	27	404 0.8×	806 1.7×	190 0.5×	368 1.9×	91 0.5×	104	2.6k
J.H. Goldie Canada	20	384 0.7×	480 1.0×	206 0.6×	38 0.2×	167 0.9×	53	1.4k
Angelo Rosolen Italy	31	907 1.8×	681 1.4×	745 2.1×	79 0.4×	315 1.7×	82	2.5k
Takao Ohnuma United States	22	592 1.1×	462 1.0×	174 0.5×	44 0.2×	86 0.5×	81	1.5k

Countries citing papers authored by R. Brian Mitchell

Since Specialization

Citations

This map shows the geographic impact of R. Brian Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Brian Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Brian Mitchell more than expected).

Fields of papers citing papers by R. Brian Mitchell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Brian Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Brian Mitchell. The network helps show where R. Brian Mitchell may publish in the future.

Co-authorship network of co-authors of R. Brian Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of R. Brian Mitchell. A scholar is included among the top collaborators of R. Brian Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Brian Mitchell. R. Brian Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Mitchell, R. Brian, Patricia Rich, Paul R. Walker, et al.. (2020). Real-world performance of blood-based host immune profiling in first-line immunotherapy treatment in advanced-stage non-small cell lung cancer.. Journal of Clinical Oncology. 38(15_suppl). 9545–9545. 1 indexed citations

Hainsworth, John D., David Waterhouse, Kent C. Shih, et al.. (2018). Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC). Lung Cancer. 118. 6–12. 6 indexed citations

Mitchell, R. Brian. (2012). Acute otitis media–induced petrous apicitis presenting as the Gradenigo syndrome: successfully treated by ventilation tube insertion. Yearbook of Otolaryngology-Head and Neck Surgery. 2012. 162–163. 2 indexed citations

Spigel, David R., Howard A. Burris, F. Anthony Greco, et al.. (2011). Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 29(18). 2582–2589. 131 indexed citations

Spigel, David R., Howard A. Burris, F. Anthony Greco, et al.. (2010). Abstract LB-77: A randomized double-blind placebo-controlled phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small cell lung cancer: Correlative analyses. Cancer Research. 70(8_Supplement). LB–77. 1 indexed citations

Hensley, Martee L., Karen L. Hagerty, Tarun Kewalramani, et al.. (2008). American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants. Journal of Clinical Oncology. 27(1). 127–145. 378 indexed citations breakdown →

Morales‐Montor, Jorge, et al.. (2001). Immunoendocrine Interactions During Chronic Cysticercosis Determine Male Mouse Feminization: Role of IL-6. The Journal of Immunology. 167(8). 4527–4533. 51 indexed citations

Hensley, Martee L., Celeste Lindley, Gail Broder, et al.. (1999). American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy Protectants. Journal of Clinical Oncology. 17(10). 3333–3355. 264 indexed citations

Mitchell, R. Brian, et al.. (1998). Carboplatin and Paclitaxel for Previously Treated Patients with Non-small-cell Lung Cancer. Cancer Investigation. 16(6). 381–384. 6 indexed citations

10.

Mitchell, R. Brian, M. Eileen Dolan, Linda Janisch, et al.. (1994). Sequential therapy with dacarbazine and carmustine: a phase I study. Cancer Chemotherapy and Pharmacology. 34(6). 509–514. 9 indexed citations

11.

Mitchell, R. Brian & M. Eileen Dolan. (1993). Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemotherapy and Pharmacology. 32(1). 59–63. 47 indexed citations

12.

Barry, Michael, David Back, AM Breckenridge, et al.. (1993). The effects of indomethacin and naproxen on zidovudine pharmacokinetics.. British Journal of Clinical Pharmacology. 36(1). 82–85. 15 indexed citations

13.

Mitchell, R. Brian, R C Moschel, & M E Dolan. (1992). Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation.. PubMed. 52(5). 1171–5. 97 indexed citations

14.

Dolan, M. Eileen, et al.. (1991). Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.. PubMed. 51(13). 3367–72. 199 indexed citations

15.

Dolan, M. Eileen, et al.. (1990). Modulation of Mammalian O⁶-Alkylguanine-DNA Alkyltransferase in vivo by O⁶-Benzylguanine and its Effect on the Sensitivity of a Human Glioma Tumor to l-(2-chloroethyl)-3-(4-methylcyclohexyl)-l-nitrosourea. PubMed. 2(11). 371–377. 84 indexed citations

16.

Mitchell, R. Brian, Judith E. Karp, Saul W. Brusilow, et al.. (1988). Syndrome of Idiopathic Hyperammonemia after High-Dose Chemotherapy: Review of Nine Cases. The American Journal of Medicine. 85(5). 662–667. 74 indexed citations

17.

Hunter, Robert, et al.. (1985). Differentiation of normal marrow and HL60 cells induced by antithymocyte globulin.. Proceedings of the National Academy of Sciences. 82(14). 4823–4827. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact